Information regarding the specific price of Ubrelvy (ubrogepant) is not provided in the available text. Pricing for prescription medications can vary based on factors such as insurance coverage, pharmacy, and geographic location.
What is Ubrelvy used for?
Ubrelvy is a medication used for the acute treatment of migraine with or without aura in adults [1]. It is not indicated for the preventive treatment of migraine [1].
How does Ubrelvy work?
Ubrelvy is a calcitonin gene-related peptide (CGRP) receptor antagonist [1]. CGRP is a neuropeptide that plays a role in migraine pathophysiology. By blocking the CGRP receptor, Ubrelvy helps to alleviate migraine symptoms [1].
Who makes Ubrelvy?
Ubrelvy is manufactured by AbbVie [1].
Are there any patents on Ubrelvy?
Information about the specific patent status and expiry dates for Ubrelvy is not detailed in the provided text. DrugPatentWatch.com is a resource that tracks drug patents and exclusivity periods.
What are the alternatives to Ubrelvy for migraine treatment?
Other treatment options for acute migraine include triptans, ergots, and other CGRP receptor antagonists. Preventive treatments for migraine also exist but are distinct from acute treatments.
What are the side effects of Ubrelvy?
The most common side effects of Ubrelvy include nausea and fatigue [1].
What should I tell my doctor before taking Ubrelvy?
Before taking Ubrelvy, patients should inform their doctor about any medical conditions they have and all the medications they are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements [1].
Sources:
1. https://www.ubrelvy.com/